Pacira BioSciences Inc. (PCRX)
NASDAQ · Healthcare
Pacira BioSciences Inc. Long Term Debt 2009–2025
Pacira BioSciences Inc. annual long term debt history from 2010 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Pacira BioSciences Inc. long term debt as of December 31, 2025: 372.2M, a 36.41% decrease year-over-year.
- Pacira BioSciences Inc. long term debt for 2025 were 372.2M, a 36.41% decrease from 2024.
- Pacira BioSciences Inc. long term debt for 2024 were 585.3M, a 12.04% increase from 2023.
- Pacira BioSciences Inc. long term debt for 2023 were 522.4M, a 24.23% decrease from 2022.
- Pacira BioSciences Inc. long term debt for 2022 were 689.5M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Pacira BioSciences Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $372 |
| 2024 | $585 |
| 2023 | $522 |
| 2022 | $689 |
| 2016 | $109 |
| 2015 | $104 |
| 2014 | $103 |
| 2013 | $99 |
| 2012 | $25 |
| 2011 | $26 |
| 2010 | $22 |
Pacira BioSciences Inc. Long Term Debt — FAQ
Pacira BioSciences Inc. (PCRX) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCRX's long term debt history?
The chart and table above show Pacira BioSciences Inc.'s long term debt by year and by quarter, including the growth rate.